Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF)

USD 56.04

(14.37%)

Gross Profit Summary of Recordati Industria Chimica e Farmaceutica S.p.A.

  • Recordati Industria Chimica e Farmaceutica S.p.A.'s latest annual gross profit in 2023 was 1.42 Billion EUR , up 10.57% from previous year.
  • Recordati Industria Chimica e Farmaceutica S.p.A.'s latest quarterly gross profit in 2024 Q1 was 415.56 Million EUR , up 16.42% from previous quarter.
  • Recordati Industria Chimica e Farmaceutica S.p.A. reported a annual gross profit of 1.28 Billion EUR in annual gross profit 2022, up 11.65% from previous year.
  • Recordati Industria Chimica e Farmaceutica S.p.A. reported a annual gross profit of 1.15 Billion EUR in annual gross profit 2021, up 10.59% from previous year.
  • Recordati Industria Chimica e Farmaceutica S.p.A. reported a quarterly gross profit of 386.22 Million EUR for 2024 Q2, down -7.06% from previous quarter.
  • Recordati Industria Chimica e Farmaceutica S.p.A. reported a quarterly gross profit of 356.94 Million EUR for 2023 Q4, up 7.07% from previous quarter.

Annual Gross Profit Chart of Recordati Industria Chimica e Farmaceutica S.p.A. (2023 - 2003)

Historical Annual Gross Profit of Recordati Industria Chimica e Farmaceutica S.p.A. (2023 - 2003)

Year Gross Profit Gross Profit Growth
2023 1.42 Billion EUR 10.57%
2022 1.28 Billion EUR 11.65%
2021 1.15 Billion EUR 10.59%
2020 1.04 Billion EUR -0.28%
2019 1.04 Billion EUR 9.23%
2018 956.66 Million EUR 5.67%
2017 905.36 Million EUR 14.17%
2016 792.98 Million EUR 11.3%
2015 712.46 Million EUR 7.9%
2014 660.3 Million EUR 7.49%
2013 614.3 Million EUR 14.87%
2012 534.76 Million EUR 6.51%
2011 502.05 Million EUR 2.87%
2010 488.06 Million EUR -4.66%
2009 511.9 Million EUR 9.51%
2008 467.43 Million EUR 10.74%
2007 422.08 Million EUR 9.87%
2006 384.17 Million EUR 2.32%
2005 375.45 Million EUR 21.49%
2004 309.03 Million EUR 7.38%
2003 287.78 Million EUR 0.0%

Peer Gross Profit Comparison of Recordati Industria Chimica e Farmaceutica S.p.A.

Name Gross Profit Gross Profit Difference
AstraZeneca PLC 34.69 Billion USD 95.899%
Bristol-Myers Squibb Company PFD CONV 2 34.31 Billion USD 95.854%
CSPC Pharmaceutical Group Limited 30.13 Billion USD 95.28%
Clarus Therapeutics Holdings, Inc. 11.23 Million USD -12560.176%
Novartis AG 34.18 Billion USD 95.839%
PT Kalbe Farma Tbk. 743.47 Million USD -91.348%